Molecular Cancer stem cell therapy: Rhamnetin, an O-methylated flavonoid and anti-inflammatory agent, suppresses the expression of activator protein-1 member Fra-1 via up regulation of its target gene, 13/March/2014, 22.17

Molecular Cancer stem cell therapy: Rhamnetin, an O-methylated flavonoid and anti-inflammatory agent, suppresses the expression of tumor suppressor p53 negative regulator HDM4/MDM4 via up regulation of its target gene, 13/March/2014, 22.14
March 13, 2014
The TII-Diabetes drug Acarbose inhibits reprogramming of differentiated cells into induced pluripotent stem cells through its target genes, 13/March/2014, 22.28
March 13, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular Cancer stem cell therapy: Rhamnetin, an O-methylated flavonoid and anti-inflammatory agent, suppresses the expression of activator protein-1 member Fra-1 via up regulation of its target gene, 13/March/2014, 22.17,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.